New Horizons in AF - Personalised AF Therapies

Published: 23 January 2020

  • Views:

    Views Icon 635
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

New Horizons in AF was a scientific meeting which highlighted current approaches to the diagnosis and treatment of atrial fibrillation. The meeting hosted faculty from across the globe and each presenter shared their personalised AF therapy strategies. Access here a collection of key presentations from the meeting.

These videos were sponsored by Boston Scientific.

Educational Objectives

  • Understand different approaches to AF diagnosis and treatment
  • Understand two new single-shot technologies
  • Understand AF treatment with RHYTHMIA HDx™

More from this programme

Part 1

Welcome & Current State of the Art

In this video, Prof John Morgan welcomes the faculty alongside co-Chair, Prof Serge Boveda, to introduce Prof Isabel Deisenhofer (German Heart Center Munich, Munich, Germany) who discusses the current tools and techniques in AF ablation.

Part 2

The Big AF Debate

Dr Serge Boveda (Toulouse, FR) moderates ‘The Big AF Debate’ session featuring Prof Richard Schilling (London, UK) and Prof Stephan Willems (Hamburg, DE) sharing their respective approaches to Atrial Fibrillation therapy. In this debate session you will see arguments comparing the cryoballoon and point-by-point ablation techniques. Prof Richard Schilling (London, UK) will provide his take on why single-shot cryoballoon ablation is preferred, whereas Prof Stephan Willems (Hamburg, DE) will champion why the radiofrequency point-by-point method is equal to or better than, single-shot tools in this engaging 'fire and ice' discussion. Debate session 1: Pro Single-shot ablation - Prof R Schilling Debate session 2: Pro radiofrequency point-by-point ablation - Prof Stephan Willems

Part 3

Introducing the AF Portfolio Proposition

In this video Prof Dhiraj Gupta (Liverpool, UK) discuss the personalised portfolio approach and considers what it means for practitioners and patients. Here he imagines the future of AF, with an examination of where AF ablation is today and where it is heading in the future.

Part 4

Personalised AF Therapies in the Hands of All EPs

In this short video interview, Prof Dhiraj Gupta (Liverpool Heart and Chest Hospital, Liverpool, UK) provides his personal views on what it means for a physician to deliver personalised AF therapy. He considers the varying presentation of AF in individual patients, the portfolio of tools and mechanisms needed to treat AF ablation in clinical practice, as well what it means to be able to deliver a personalised electrophysiology strategy.

Part 5

Ultra-HD Mapping and Ablation

In this video Dr Christian Meyer (Evangelisches Krankenhaus, Düsseldorf, DE) discusses the advantages of Ultra-HD mapping solutions for a faster and more efficient workflow for Atrial Ablation procedures.

Part 6

Go Beyond Conventional Persistent AF Mapping

In this video Dr Gabriel Latçu (Centre Hospitalier Princesse Grace, Monaco) discusses persistent AF mapping strategies.

Faculty Biographies

Isabel Deisenhofer

Isabel Deisenhofer

Prof Isabel Deisenhofer is an electrophysiologist at the German Heart Center Munich, Germany. Prof Deisenhofer's specialities include arrythmias, atrial fibrillation, ventricular arrythmias and sudden cardiac death.

View full profile
John Morgan

John Morgan

Professor John Morgan is an honorary professor of Cardiac Rhythm Management, Cardiology at the University of Southampton. Prof Morgan specialises in cardiac arrhythmias and is the CMO EMEA, Rhythm Management, Boston Scientific.

 

View full profile
Serge Boveda

Serge Boveda

Prof Dr Serge Boveda, Clinique Pasteur, Toulouse, FRProf Dr Boveda (MD, PhD, FESC, FEHRA) is a specialist in cardiovascular diseases and the interventional treatment of cardiac arrhythmias since 1994. He is co-head of the Cardiac Arrhythmia Management Department at the Clinique Pasteur Toulouse (France), and Guest Professor for education in the postgraduate course of EP & Pacing, and research in the domain of EP at the Brussels University of Medicine (VUB).He is currently the president of the arrhythmia working group of the French Society of Cardiology (SFC) since 2018, and faculty of the French national graduation on cardiac arrhythmias (Diplôme Inter Universitaire de Rhythmologie) since 2002.Finally he is the co-founder and coordinator of the European Network for the Treatment of Cardiac Arrhythmias (RETAC), and the co-chair of EHRA's Scientific Documents Committee in 2018-2020.

View full profile